| |
| | CIPO - Canadian Patent Database - Claims - 2425558 |
 | | A crystalline (N)-((S)-2-hydroxy-3-methyl-butyryl)1-(L-alaninyl)-(S)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3benzazepin-2-one anhydrate of Claim 1 further characterized by the X-ray powder diffraction pattern comprising a peak at 4.53, 5.36, 9.04, 9.52, 9.79, 11.69, 12.46, 13.91, 14.72, 16.21, 17.92, or 19.10 (2.theta. |
 | | A crystalline (N)-((S)-2-hydroxy-3-methyl-butyryl)1-(L-alaninyl)-(S)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3benzazepin-2-one anhydrate of Claim 1 further characterized by the X-ray powder diffraction pattern comprising peaks at; 9.52 and. |
 | | A crystalline (N)-((S)-2-hydroxy-3-methyl-butyryl)1-(L-alaninyl)-(S)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3benzazepin-2-one anhydrate of Claim 1 further characterized by the X-ray powder diffraction pattern comprising peaks at 9.52, 9.79, and 12.46 (2.theta. |
| patents1.ic.gc.ca /claims?patent_number=2425558&language= (643 words) |
|